Novo Nordisk will join lawsuit over end of semaglutide shortage
Novo Nordisk got the green light to join a lawsuit by compounders against the FDA after the agency deemed that the Danish pharma's blockbuster weight loss drug was no longer in shortage. Judge Mark Pittman ...
